Biological Properties and Growth in SCID Mice of a New Myelogenous Leukemia Cell Line (KBM-5) Derived from Chronic Myelogenous Leukemia Cells in the Blastic Phase

Cancer Research

Volumn 53, Issue 15, 1993, Pages 3603-3610

  Pisa, Pavel ^b   O'Brien, Susan ^a   Andersson, Borje S ^a   Kohli, Vipin ^a   Kantarjian, Hagop ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; DIMETHYL SULFOXIDE; DNA; GAMMA INTERFERON; HEMIN; RETINOIC ACID; TUMOR NECROSIS FACTOR ALPHA;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INVASION; CASE REPORT; CELL DIFFERENTIATION; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; METASTASIS POTENTIAL; MOUSE; MYELOBLAST; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

AGED; ANIMAL; BASE SEQUENCE; BLAST CRISIS; CELL DIFFERENTIATION; CHROMOSOME ABERRATIONS; CYTOKINES; FEMALE; FUSION PROTEINS, BCR-ABL; HUMAN; ISOENZYMES; KILLER CELLS, NATURAL; LEUKEMIA, MYELOID, CHRONIC; MICE; MICE, SCID; MOLECULAR SEQUENCE DATA; PHENOTYPE; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0027169552     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Canellos, G.P. Chronic granulocytic leukemia. Med. Clin. North Am., 60: 1001, 1976.
2. Kantarjian, H., and Talpaz, M. Treatment of chronic myelogenous leukemia. In: E.J. Freireich and H. Kantarjian (eds.), Therapy of Hematopoietic Neoplasia, p. 105. New York: Marcel Dekker, 1991.
3. Golde, D.W., and Champlin, R.E. Chronic myelogenous leukemia: recent advances. Blood. 65: 1039, 1985.
4. Thomas, E.D., Cliff, R.A., Fefer, A., Appelbaum, F. R., Beatty, P., Bensinger, W.I., Buckner, D., Cheever, M.A., Deeg, H.J., Doney, K., Flournoy, N., Greenberg, P., Hansen, J.A., Martin, P., McGuffin, R., Ramberg, R., Sanders, J.E., Singer, J., Stewart, P., Storb, R., Sullivan, K., Weiden, P.L., and Witherspoon, R. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann. Intern. Med., 104: 155-163. 1986.
5. Kantarjian, H.M., Keating, M.J., Talpaz, M., Walters, R.S., Smith, T.L., Cork, A., McCredie, K.B., and Freireich, E.J. Chronic myelogenous leukemia in blast crisis: analysis of 242 patients. Am. J. Med., 83: 445-454, 1987.
6. Goldman, J.M., Apperley, J.F., Jones, L., Marcus, R., Goolden, A.W., Batchelor, R., Hale, G., Waldmann, H., Reid, C.D., Hows, J., Gordon-Smith, E., Catovsky, D., and Galton, D.A. Bone marrow transplantation for patients with chronic myeloid leukemia. N. Engl. J. Med., 314: 202-207, 1986.
7. Lozzio, C.B., and Lozzio, B.B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood, 45: 321, 1975.
8. Papayannopoulou, T. HEL cells: a new human erythroleukemia cell line with spontaneous and induced globulin expression. Science (Washington DC), 216: 1233, 1982.
9. Keating, A., Martin, I.D., Berstein, I.D., Papayannopoulou, T., Raskind, W., and Singer, J.W. EM-2 and EM-3: two new Ph1 + myeloid cell lines. Normal and Neoplas. Hemat., p. 513, 1983.
10. Pegoraro, L., Matera, L., Ritz, J., Levis, A., Palumbo, A., and Biagini, G. Establishment of a Ph1-positive human cell line (BV173). J. Natl. Cancer Inst., 70: 447, 1983.
11. Kubonishi, I., and Miyoshi, I. Establishment of a Ph1 chromosome-positive cell line from chronic myelogenous leukemia in blast crisis. Int. J. Cell Cloning, 1: 105, 1983.
12. Ogura, M., Morishima, Y., Ohno, R., Kato, Y., Hirabayashi, N., Nagura, H., and Saito, H. Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome. Blood, 66: 1384, 1985.
13. Ohkubo, T., Kamamoto, T., Kita, K., Hiraoka, A., Yoshida, Y., and Uchino, H. A novel Ph1 chromosome positive cell line established from a patient with chronic myelogenous leukemia in blastic crisis. Leuk. Res., 9: 921, 1985.
14. Andersson, B.S., Beran, M., Pathak, S., Goodacre, A., Barlogie, B., and McCredie, K.B. Ph-positive chronic myeloid leukemia with near-haploid conversion in vivo and establishment of a continuously growing cell line with similar cytogenetic pattern. Cancer Genet. Cytogenet., 24: 335, 1987.
15. Ohta, M., Furukawa, Y., Ide, C.H., Akiyama, N., Utakojii, T., Miura, Y., and Saito, M. Establishment and characterization of four human monocytoid leukemia cell lines (JOSK-I, -5, -M, -K) with capabilities of monocyte-macrophage lineage differentiation and constitutive production of interleukin 1. Cancer Res., 46: 3067, 1986.
16. Seignewrin, D., Champelovier, P., Monchiroud, G., Berthier, R., Leroux, D., Prenant, M., McGregor, J., Starch, J., Morle, F., Miconin, C., Pietrantuous, A., and Kolodie, L. Human chronic myeloid leukemic cell line with positive Philadelphia chromosomes exhibits megakaryocytic and erythroid characteristics. Exp. Hematol., 15: 822, 1979.
17. Okabe, M., Matsushima, S., Morika, M., Kobayashi, M., Abe, S., Sakurada, K., Kakinuma, and Miyazaki, T. Establishment and characterization of a cell line, TOM-1, derived from a patient with Philadelphia chromosome-positive acute lymphocytic leukemia. Blood, 69: 990, 1987.
18. Youness, E., Trujillo, J.M., Ahern, M.J., McCredie, K.B., and Cork, A. Acute unclassified leukemia: clinicopathologic study with diagnostic amplifications of electron microscopy. Am. J. Hematol., 9: 79, 1980.
19. Stass, S.A., Schumacher, H.R., Kenekiis, T.P., and Bollum, F.J. Terminal deoxynucleotidyl transferase immunofluorescence of bone marrow smears: experience in 156 cases. Am. J. Clin. Pathol., 72: 898, 1979.
20. Reedman, B.M., and Klein, G. Cellular localization of an Epstein-Barr virus (EBV) associated complement fixation antigen in producer and non-producer lymphoid cell lines. Int. J. Cancer, 11: 499, 1973.
21. Saito, I., Servenius, B., Compton, T., and Fox, R.I. Detection of Epstein-Barr virus by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. J Exp. Med., 169: 2191, 1989.
22. Siciliano, M.J., and Shaw, C.R. Separation and visualization of enzymes on gels. In: I. Smith and J.W.T. Seakins (eds.), Chromatographic and Electrophoretic Techniques, Vol. 2, Ed. 4, p. 985. London: W. Heinemann, 1976.
23. Rutsky, L.P., and Siciliano, M.J. Various isozyme gene expression patterns among colorectal adenocarcinoma cell lines and tissues. J. Natl. Cancer Inst., 68: 81, 1982.
24. Pathak, S. Chromosome banding techniques: J. Reprod. Med., 17: 25, 1976.
25. Kloetzer, W., Kurzrock, R., Smith, L., Talpaz, M., Spiller, M., Gutterman, J.U., and Arlinghaus, R. The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity. Virology, 140: 230-238, 1985.
26. Shtievelman, E., Lifshitf, B., Robert, P., Canaani, G., and Canaani, E. Fused transcripts of abl and bcr genes in chronic myelogenous leukemia. Nature (Lond.), 315: 550, 1985.
27. Spiegelberg, H.L., and Gonzales-Molina, A. Rosette assay for membrane receptors on human lymphocyte subpopulations. In: R.M. Makamura, W.R. Dito, and R.S. Tucker III (eds.), Laboratory and Research Methods in Biology and Medicine, Vol. 4, pp. 287-300. New York: Allan R. Liss, Inc., 1980.
28. Beran, M., Hansson, M., and Kiessling, R. Human natural killer cells can inhibit clonogenic growth of fresh leukemic cells. Blood, 61: 5%, 1983.
29. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid gnanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 163: 1566, 1987.
30. Lee, M.S., Chang, K.S., Freireich, E.J., Kantarjian, H.M., Talpaz, M., Trujillo, J.M., and Stass, S. Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reaction. Blood, 72: 893, 1988.
31. Lee, M.S., LeMaistre, A., Kantarjian, H.M., Talpaz, M., Freireich, E.J., Trujillo, J.M., and Stass, S.A. Detection of two alternative bcr/abl mRNAs and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction. Blood, 73: 2165, 1989.
32. Kurzrock, R., Gutterman, J.U., and Talpaz, M. The molecular genetics of Phildelphia chromosome-positive leukemias. N. Engl. J. Med., 319: 990, 1988.
33. Kawasaki, E.S., Clark, S.S., Coyne, M.Y., Smith, S.D., Champlin, R., Witte, O.N., and McCormick, F.P. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc. Natl. Acad. Sci. USA, 85: 5697, 1988.
34. Kurzrock, R., Kloetzer, W.S., Talpaz, M., Blick, M., Walters, R., Arlinghaus, R.B., and Gutterman, J.U. Identification of molecular variants of p. 10bcr-abl in chronic myelogenous leukemia. Blood, 70: 233, 1987.
35. Dhingra, K., Talpaz, M., Rigs, M.G., Eastman, P.S., Zipf, T., Ku, S., and Kurzrock, R. Hybridization protection assay: a rapid, sensitive, and specific method for detection of Philadelphia chromosome-positive leukemias. Blood, 77: 238, 1991.
36. Pisa, E.K., Pisa, P., Hansson, M., and Wigzell, H. OKT3 induced cytokine mRNA expression in human peripheral blood mononuclear cells measured by polymerase chain reaction. Eur. J. Immunol., in press, 1992.
37. Kawasaki, E.S. Sample preparation from blood cells and other fluids. In: M.A. Innis, D.H. Gelfband, J.J. Sninsky, and T.J. White (eds.) PCR Protocols: A Guide to Methods and Applications, p. 146. San Diego, CA: Academic Press, 1990.
38. Saiki, R.K., Bugawan, T.L., Horn, G.T., Mullis, K.B., and Ehrlich, H.A. Analysis of enzymatically amplified ß-globlin and HLA-DQ a DNA with allele-specific oligonucleotide probes. Nature (Lond.), 324: 163, 1986.
39. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R., and Sultan, C. Proposed revised criteria for the classification of acute myelogenous leukemia. Ann. Intern. Med., 103: 626, 1985.
40. Griffin, J.D., Mayer, R.J., Weinstein, H.J., Rosenthal, D.S., Coral, F.S., Beveridge, R.P., and Schlossman, S.F. Surface marker analysis of acute myeloblastic leukemia: identification of differentiation-associated phenotypes. Blood, 62: 557, 1983.
41. Andersson, B.S., Bergenheim, U.S.R., Collins, V.P., Childs, C., Beran, M., Sen, S., Arden, K., Pathak, S., Siciliano M.J., Ost, A., and Freireich, E.J. KBM-3, an in vitro model of human acute myelomonocytic leukemia. Exp. Hematol., 20: 361, 1982.
42. Konopka, J.B., Watanabe, S.M., and Witte, O.N. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell, 37: 1035, 1984.
43. Groffen, J., Stephenson, J.R., Heisterkamp, N., de Klein, A., Bartram, C.R., and Grosveld, G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell, 36: 93, 1984.
44. Nowell, P.C., and Hungerford, D.A. A minute chromosome in human chronic granulocytic leukemia. Science (Washington DC), 132: 1197, 1960.
45. Rowley, J.D. Chromosome abnormalities in human leukemia. Annu. Rev. Genet., 14: 17-39, 1980.
46. Blick, M., Andersson, B.S., Beran, M., Romero, P., Talpaz, M., and Gutterman, J. The c-abl, bcr and c-genes are amplified in a cell line but not in the uncultured cells from a patient with chronic myelogenous leuekemia. Leuk. Res, 10: 1401, 1986.
47. Beran, M., Andersson, B.S., Kelleher, P., Whalen, K., McCredie, K.B., and Gutterman, J. Diversity of the effect of recombinant tumor necrosis factors a and ß on human myelogenous leukemia cell lines. Blood, 69: 721, 1987.
48. Sawyers, C.H.L., Gishizky, M.L., Quan, S., Golde, D.N., and Witte, O.N. Propagation of human blastic myeloid leukemias in the SCID mouse. Blood, 79: 2089, 1992.
49. DeLord, C., Clutterbuck, R., Tilley, J., Ormerod, M., Gordon-Smith, T., Millar, J., and Powles, R. Growth of primary human acute leukemia in severe combined immunodeficient mice. Exp. Hematol., 18: 991, 1991.